CVS Health Corp (CVS) Shares Sold by Ipswich Investment Management Co. Inc.

Ipswich Investment Management Co. Inc. lowered its position in CVS Health Corp (NYSE:CVS) by 51.2% during the fourth quarter, Holdings Channel reports. The fund owned 3,103 shares of the pharmacy operator’s stock after selling 3,250 shares during the quarter. Ipswich Investment Management Co. Inc.’s holdings in CVS Health were worth $225,000 at the end of the most recent quarter.

Other institutional investors have also recently modified their holdings of the company. Fieldpoint Private Securities LLC boosted its holdings in CVS Health by 333.3% in the second quarter. Fieldpoint Private Securities LLC now owns 1,300 shares of the pharmacy operator’s stock valued at $105,000 after acquiring an additional 1,000 shares during the last quarter. Wealthcare Advisory Partners LLC boosted its holdings in CVS Health by 330.3% in the third quarter. Wealthcare Advisory Partners LLC now owns 1,291 shares of the pharmacy operator’s stock valued at $105,000 after acquiring an additional 991 shares during the last quarter. Arcadia Investment Management Corp MI boosted its holdings in CVS Health by 119.6% in the third quarter. Arcadia Investment Management Corp MI now owns 1,333 shares of the pharmacy operator’s stock valued at $108,000 after acquiring an additional 726 shares during the last quarter. MPS Loria Financial Planners LLC acquired a new position in CVS Health in the second quarter valued at $119,000. Finally, Captrust Financial Advisors acquired a new position in CVS Health in the second quarter valued at $155,000. Hedge funds and other institutional investors own 83.23% of the company’s stock.

Shares of CVS Health Corp (NYSE CVS) opened at $68.00 on Friday. CVS Health Corp has a 52-week low of $66.45 and a 52-week high of $84.00. The stock has a market capitalization of $69,759.22, a PE ratio of 11.61, a PEG ratio of 1.17 and a beta of 0.93. The company has a debt-to-equity ratio of 0.59, a quick ratio of 0.52 and a current ratio of 1.02.

CVS Health (NYSE:CVS) last announced its earnings results on Thursday, February 8th. The pharmacy operator reported $1.92 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.88 by $0.04. CVS Health had a return on equity of 17.21% and a net margin of 3.58%. The business had revenue of $48.39 billion for the quarter, compared to analyst estimates of $47.54 billion. During the same period in the previous year, the company earned $1.71 earnings per share. The company’s revenue for the quarter was up 5.3% compared to the same quarter last year. research analysts predict that CVS Health Corp will post 6.37 EPS for the current year.

The firm also recently announced a quarterly dividend, which was paid on Friday, February 2nd. Stockholders of record on Wednesday, January 24th were given a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.94%. The ex-dividend date was Tuesday, January 23rd. CVS Health’s payout ratio is 30.91%.

CVS has been the topic of a number of recent research reports. Citigroup set a $77.00 price objective on CVS Health and gave the stock a “neutral” rating in a research note on Tuesday, February 13th. Leerink Swann set a $85.00 price objective on CVS Health and gave the stock a “buy” rating in a research note on Friday, February 9th. Robert W. Baird reduced their price objective on CVS Health from $85.00 to $80.00 and set a “neutral” rating on the stock in a research note on Friday, February 9th. Royal Bank of Canada set a $89.00 price objective on CVS Health and gave the stock a “buy” rating in a research note on Thursday, February 8th. Finally, Needham & Company LLC set a $98.00 price objective on CVS Health and gave the stock a “buy” rating in a research note on Friday, February 9th. Two equities research analysts have rated the stock with a sell rating, seven have issued a hold rating, twelve have given a buy rating and two have issued a strong buy rating to the company. The stock has a consensus rating of “Buy” and a consensus target price of $87.82.

In related news, EVP Helena Foulkes sold 19,965 shares of the business’s stock in a transaction dated Friday, February 16th. The stock was sold at an average price of $71.04, for a total value of $1,418,313.60. Following the completion of the sale, the executive vice president now directly owns 65,072 shares of the company’s stock, valued at $4,622,714.88. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, EVP Lisa Bisaccia sold 29,445 shares of the business’s stock in a transaction dated Thursday, December 21st. The shares were sold at an average price of $75.00, for a total value of $2,208,375.00. Following the completion of the sale, the executive vice president now directly owns 15,556 shares of the company’s stock, valued at $1,166,700. The disclosure for this sale can be found here. 0.61% of the stock is currently owned by insiders.

TRADEMARK VIOLATION WARNING: This report was first posted by StockNewsTimes and is the property of of StockNewsTimes. If you are reading this report on another publication, it was illegally copied and reposted in violation of international trademark and copyright law. The original version of this report can be read at https://stocknewstimes.com/2018/02/23/cvs-health-corp-cvs-shares-sold-by-ipswich-investment-management-co-inc.html.

CVS Health Profile

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corp (NYSE:CVS).

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply